Drug-induced hypersensitivity syndrome like reaction with angioedema and hypotension associated with BRAF inhibitor use and antecedent immune checkpoint therapy.
JAAD Case Rep
; 13: 147-151, 2021 Jul.
Article
en En
| MEDLINE
| ID: mdl-34195327
BRAF; BRAF inhibitor; BRAFi, BRAF inhibitors; CTLA4; DIHS; DIHS, drug-induced hypersensitivity syndrome; DLR, DIHS-like reaction; DRESS; ICI; ICI, immune checkpoint inhibitor; PD-1; PD-L1; PD1; TT, targeted therapy; dabrafenib; encorafenib; immune checkpoint therapy; immune related adverse effect; irAE; ircAE; oncoderm; rash; vemurafenib
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Risk_factors_studies
Idioma:
En
Revista:
JAAD Case Rep
Año:
2021
Tipo del documento:
Article